Home Newsfeeds Barclays Maintains Overweight on Marathon Oil, Raises Price Target to $35

Barclays Maintains Overweight on Marathon Oil, Raises Price Target to $35

Barclays analyst Jeanine Wai maintains Marathon Oil (NYSE:MRO) with a Overweight and raises the price target from $34 to $35.

byBenzinga Newsdesk

December 7, 2022

1 minute read

Barclays analyst Jeanine Wai maintains Marathon Oil (NYSE:MRO) with a Overweight and raises the price target from $34 to $35.

Jefferies Maintains Buy on Staar Surgical, Lowers Price Target to $125

By Benzinga Newsdesk

August 11, 9:37 AM

Jefferies analyst Zachary Weiner maintains Staar Surgical (NASDAQ:STAA) with a Buy and lowers the price target from $165 to $125.

STAA

CytoSorbents Receives $5M In Non-Dilutive Debt Financing From Bridge Bank And Extends Loan Agreement

By Bill Haddad

December 29, 8:01 AM

PRINCETON, N.J., Dec. 29, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery

CTSO

General Motors’ Ultium Cells Agrees To Boost Wages At Its Ohio Battery Plant

By Shivani Kumaresan

August 25, 8:28 AM

General Motors Company (NYSE: GM) JV-owned Ultium Cells has agreed to immediately raise wages by $3 to $4 an hour at its battery plant in Ohio. Ultium Cells is a joint venture between General Motors and LG Energy Solution.